USTR Froman: IP-Related Biologics Still Key Sticking Point For TPP Passage In US 20/06/2016 by William New, Intellectual Property Watch 1 Comment United States Trade Representative Michael Froman today said biologics remain one of the biggest unresolved issues in getting the Trans-Pacific Partnership passed in the US Congress. He called biologics an intellectual property rights issue and said the administration is working with Congress and industry to resolve concerns without reopening the trade deal completed last autumn.
European Council Approves First-Ever Analysis Of Drug Prices With Look At IP Rights 17/06/2016 by William New, Intellectual Property Watch 3 Comments The 28 European Union governments today gave final approval to a first-ever plan to analyse medicines competition in Europe, with reference to drug prices, generics and biosimilars, and intellectual property rights. The final version was watered down after what sources said was heavy industry lobbying, compared to a leaked version published in Intellectual Property Watch two weeks ago, but still retains some strong provisions regarding pricing and competition.
WHO/PAHO New Response Plan For Zika Until December 2017 17/06/2016 by Intellectual Property Watch Leave a Comment A new response plan for a strategic response to the Zika virus has been announced by the World Health Organization and the Pan American Health Organization.
European Council Conclusions On Steps To Combat Antimicrobial Resistance 17/06/2016 by Intellectual Property Watch 1 Comment The 28 European Union member governments have concluded next steps for addressing antimicrobial resistance, with a strong emphasis on reducing use of antibiotics in animals, but also including a call for new business models.
Panels Brainstorm Ideas On Innovation And Drug Access 15/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The quest of balance between encouraging medical innovation and the imperative of broad access to medicines has so far been elusive. Two Harvard University programmes jointly organised a workshop this week with the aim of encouraging a conversation between global health actors and see if some “outside the box” thinking is possible.
UN Development Agency Issues Guidelines For Pharmaceutical Patent Examiners 15/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products. The guidelines, written by a well-known advocate of access to medicines, aim at advising patent examiners in assessing the patentability requirements of applications relating to pharmaceutical products and processes.
Innovation et accès : fission ou fusion ? Entretien avec Tim Wilsdon, Vice-président de CRA 14/06/2016 by William New, Intellectual Property Watch Leave a Comment Dans le sillage du Groupe de Haut Niveau des Nations Unies sur l’accès aux médicaments, cette série d’articles sponsorisés convie des experts à donner leur point de vue sur les politiques les mieux à même de favoriser l’élaboration de solutions aux plus importants enjeux sociétaux ; ils nous expliquent aussi comment un cadre réglementaire favorable, y […]
Alongside UN Commitments To End AIDS, Event On Access Brings Tears, Vision 13/06/2016 by William New, Intellectual Property Watch 1 Comment NEW YORK — Last week, United Nations members agreed on a political declaration on ending AIDS by 2030, with some new and old commitments. Alongside the 8-10 June High-Level Meeting on Ending AIDS, a side event looked at issues of access and got into intellectual property rights issues.
Amid Allegations Of IP Theft By Corporations, Local Kenyan Innovators React 10/06/2016 by Fredrick Nzwili for Intellectual Property Watch 3 Comments NAIROBI, Kenya – As start-up and innovation centres spring up across Africa, Kenya – which birthed the continent’s tech movement – is emerging as one of its leading innovation nuclei. But concerns are intensifying here that young inventors are losing their innovations to conglomerates, in what is alleged as intellectual property theft or abuse.
Kenya’s Fledgling Innovation Agency Could Be Dissolved 10/06/2016 by Maina Waruru for Intellectual Property Watch 1 Comment NAIROBI, Kenya — Kenya could disband its infant innovation agency and have its functions taken up by the state’s science, technology and innovation body, if changes suggested by the government to reform the science, technology and innovation (ST&I) sector are carried through.